ReviewJournal of fungi (Basel, Switzerland)2017
Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis.
Review in Journal of fungi (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 37 citations in OpenAlex.
- Phylogenetic and Structural Analysis of Miconazole Susceptibility in Malassezia pachydermatis Isolates From Dogs With Otitis Externa.Veterinary dermatology · 2026Article
- Article
- Antifungal Susceptibility ofAntibiotics (Basel, Switzerland) · 2025Article
- Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.Mycoses · 2025Article
- The Efficacy of a Combination of Selected Azole Antifungals and Plant Essential Oil Components AgainstJournal of fungi (Basel, Switzerland) · 2025Article
- Antifungal properties of carvone and linalool againstCurrent medical mycology · 2024Article
- Antimicrobial Susceptibility Testing for ThreeMicrobiology spectrum · 2023Article
- ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis.Mycopathologia · 2023Article
- Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.Drug delivery and translational research · 2022Article
- In Vitro Biofilm Formation byJournal of fungi (Basel, Switzerland) · 2022Article
- Many ways, one microorganism: Several approaches to study Malassezia in interactions with model hosts.PLoS pathogens · 2022Review
- Review
- InvasiveCase reports in infectious diseases · 2022Article
- In vitro and in vivo evaluation of a new phytotherapic blend to treat acute externa otitis in dogs.Journal of veterinary pharmacology and therapeutics · 2021Article
- Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI).Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020Review
- Antifungal Resistance RegardingJournal of fungi (Basel, Switzerland) · 2020Review
- New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections.Scientific reports · 2020Article
- Review
- Azole resistance ofMedical mycology case reports · 2019Article
- A Ketoconazole Susceptibility Test forJournal of fungi (Basel, Switzerland) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reference methods for antifungal susceptibility testing of yeasts have been developed by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antibiotic Susceptibility Testing (EUCAST). These methods are intended to test the main pathogenic yeasts that cause invasive infections, namely
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.